Literature DB >> 2992808

B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.

K Matsushima, Y D Kuang, G Tosato, S J Hopkins, J J Oppenheim.   

Abstract

The relationship of production of interleukin 1 (IL-1)-like factor to accessory function of Epstein-Barr virus (EBV)-transformed B lymphocytes was examined. Six of eight human EBV-B cell lines spontaneously produced and released detectable levels of thymocyte comitogenic factor in vitro, but no interleukin 2 (IL-2) activity. Eight of eight produced fibroblast proliferation activity. Culture supernatants from the two apparent nonproducers of thymocyte comitogenic activity induced the proliferation of the IL-1-dependent murine helper-T-cell clone D10G4.1 in the presence of concanavalin A (Con A). One of the EBV-B cell lines produced a potent inhibitory factor in addition to IL-1-like thymocyte comitogenic and fibroblast proliferation factors. The inhibitory factor inhibited mouse thymocyte proliferative response to Con A, and the proliferation of the IL-2-dependent CT6 cell line, but not human fibroblast growth. All but one of the eight EBV-B cell lines tested, the exception being the line that produced an inhibitory factor, were able to serve as antigen-presenting cells that enabled purified human T lymphocytes to proliferate in one-way mixed lymphocyte reactions (MLR) and in response to Con A. The supernatants of 14 of 16 clones derived from two of the EBV-B cell line cells contained thymocyte comitogenic activity and all 16 stimulated fibroblast proliferation. The phenotypic characteristics of the EBV-B cell lines were heterogeneous, but there was no clear-cut relationship between the cell surface phenotypes of either the cloned or uncloned EBV-B cells and their ability to produce these factors. These studies show that all of the EBV-B cell lines that can function as accessory cells have the capacity to produce an IL-1-like factor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992808     DOI: 10.1016/0008-8749(85)90264-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

1.  Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.

Authors:  P Busson; K Braham; G Ganem; F Thomas; D Grausz; M Lipinski; H Wakasugi; T Tursz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

2.  Interleukin 6 gene expression in normal and neoplastic B cells.

Authors:  G J Freeman; A S Freedman; S N Rabinowe; J M Segil; J Horowitz; K Rosen; J F Whitman; L M Nadler
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.

Authors:  K Ahmed; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1.

Authors:  B A Blazar; A M Murphy
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

5.  Spontaneous production of thymocyte-activating factor by human gingival fibroblasts and its autoregulatory effect on their proliferation.

Authors:  Y Ohmori; S Hanazawa; S Amano; T Miyoshi; K Hirose; S Kitano
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

Review 6.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

7.  Interleukin-1beta expression in human gastric carcinoma with Epstein-Barr virus infection.

Authors:  Ja-Mun Chong; Kazuya Sakuma; Makoto Sudo; Toshio Osawa; Etsuko Ohara; Hiroshi Uozaki; Junji Shibahara; Kenji Kuroiwa; Shin-Ichi Tominaga; Yoshitaka Hippo; Hiroyuki Aburatani; Nobuaki Funata; Masashi Fukayama
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Complete nucleotide sequence of the gene for human interleukin 1 alpha.

Authors:  Y Furutani; M Notake; T Fukui; M Ohue; H Nomura; M Yamada; S Nakamura
Journal:  Nucleic Acids Res       Date:  1986-04-25       Impact factor: 16.971

9.  The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells.

Authors:  S Swendeman; D A Thorley-Lawson
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

10.  Caspase-1 promotes Epstein-Barr virus replication by targeting the large tegument protein deneddylase to the nucleus of productively infected cells.

Authors:  Stefano Gastaldello; Xinsong Chen; Simone Callegari; Maria G Masucci
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.